GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gaush Meditech Ltd (HKSE:02407) » Definitions » Ending Cash Position

Gaush Meditech (HKSE:02407) Ending Cash Position : HK$450 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Gaush Meditech Ending Cash Position?

Gaush Meditech's Ending Cash Position for the quarter that ended in Dec. 2024 was HK$450 Mil.

Gaush Meditech's quarterly Ending Cash Position declined from Dec. 2023 (HK$677 Mil) to Jun. 2024 (HK$589 Mil) and declined from Jun. 2024 (HK$589 Mil) to Dec. 2024 (HK$450 Mil).

Gaush Meditech's annual Ending Cash Position declined from Dec. 2022 (HK$806 Mil) to Dec. 2023 (HK$677 Mil) and declined from Dec. 2023 (HK$677 Mil) to Dec. 2024 (HK$450 Mil).

Gaush Meditech Ending Cash Position Historical Data

The historical data trend for Gaush Meditech's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gaush Meditech Ending Cash Position Chart

Gaush Meditech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial 364.51 745.70 805.74 676.72 449.96

Gaush Meditech Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only 805.74 702.76 676.72 588.70 449.96

Gaush Meditech Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Gaush Meditech's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=660.564+-210.606
=450

Gaush Meditech's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=583.845+-133.887
=450

Gaush Meditech Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Gaush Meditech's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Gaush Meditech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gaush Meditech Ltd (HKSE:02407) » Definitions » Ending Cash Position
Comparable Companies
HKSE:02170 HKSE:06609 HKSE:06922 HKSE:02500 HKSE:06118 HKSE:02216 HKSE:01612 HKSE:02297 HKSE:02393 HKSE:01696 ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE
Traded in Other Exchanges
F7Y:Germany
Address
No.11 Dongzhimen South Avenue, Room 1901, Building A, Zhonghui Plaza, Dongcheng District, Beijing, CHN
Website
https://www.gaush.com
Gaush Meditech Ltd is a provider of a broad spectrum of ophthalmic medical devices. The segments of the company include 1) Proprietary products segment develops and produces surgical equipment and related supporting software, intra-optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables independently; 2) Distribution products segment sells multi-function diagnostic equipment, ocular fundus diagnosis, surgical and treatment equipment and related supporting consumables produced by ophthalmic medical equipment manufacturers; 3) Technical services segment provides warranty services, maintenance services and after-sales services related consumables; and 4) Others segment.
Executives
Orbimed Advisors Iii Limited 2102 Investment manager
Orbimed Asia Gp Iii, L.p. 2102 Investment manager
Orbimed Asia Partners Iii, L.p. 2102 Investment manager
Gao Tieta 2201 Interest of corporation controlled by you
Gaush Holding Ltd 2101 Beneficial owner
Cuprite Gem Investments Ltd 2101 Beneficial owner
Warburg Pincus (bermuda) Private Equity Gp Ltd. 2201 Interest of corporation controlled by you
Warburg Pincus (cayman) China-southeast Asia Ii Gp Llc 2201 Interest of corporation controlled by you
Warburg Pincus (cayman) China-southeast Asia Ii Gp, L.p. 2201 Interest of corporation controlled by you
Warburg Pincus China-southeast Asia Ii (cayman), L.p. 2201 Interest of corporation controlled by you
Warburg Pincus Partners Ii (cayman), L.p. 2201 Interest of corporation controlled by you

Gaush Meditech Headlines

No Headlines